Live Breaking News & Updates on Pharmaceuticals company profile

Stay informed with the latest breaking news from Pharmaceuticals company profile on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pharmaceuticals company profile and stay connected to the pulse of your community

Cantor Fitzgerald Reaffirms Overweight Rating for ACADIA Pharmaceuticals (NASDAQ:ACAD)

ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report)‘s stock had its “overweight” rating reaffirmed by research analysts at Cantor Fitzgerald in a report released on Tuesday, Benzinga reports. They presently have a $37.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 118.16% from the company’s current price. […]

Canada , United-states , America , Brendan-teehan , Robertw-baird , Stephen-davis , Acadia-pharmaceuticals , Mutual-of-america-capital-management , Royal-bank , Pharmaceuticals-inc , Nasdaq , Pharmaceuticals-price-performance

ACADIA Pharmaceuticals (NASDAQ:ACAD) Sets New 52-Week Low at $16.60

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s stock price reached a new 52-week low during trading on Tuesday . The stock traded as low as $16.60 and last traded at $16.74, with a volume of 1475997 shares. The stock had previously closed at $16.99. Analyst Ratings Changes A number of analysts recently issued reports […]

United-states , Canada , Brendan-teehan , James-kihara , Zurcher-kantonalbank-zurich-cantonalbank , Pharmaceuticals-inc , Pharmaceuticals-daily , Nasdaq , Acadia-pharmaceuticals-inc , Mirae-asset-global-investments-co , Raymond-james-associates , Pharmaceuticals-trading-down

TRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated by Analysts at StockNews.com

TRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated by Analysts at StockNews.com
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United-states , Nasdaq , Renaissance-technologies , York-mellon-corp , Pharmaceuticals-company-profile , Pharmaceuticals-inc , Pharmaceuticals-daily , Pharmaceuticals-stock , Virtu-financial , Millennium-management , Ci-private-wealth

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) VP Sells $16,947.50 in Stock

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) VP Meredith Cook sold 250 shares of ANI Pharmaceuticals stock in a transaction on Friday, April 12th. The shares were sold at an average price of $67.79, for a total value of $16,947.50. Following the transaction, the vice president now owns 59,731 shares in the company, valued […]

Canada , Blackrock , Nova-scotia , United-states , Meredith-cook , Pharmaceuticals-inc , Pharmaceuticals-company-profile , Invesco-ltd , Ani-pharmaceuticals-inc , Blackrock-inc , Balyasny-asset-management , Pharmaceuticals-stock-performance

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Short Interest Up 5.4% in March

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 11,200,000 shares, an increase of 5.4% from the March 15th total of 10,630,000 shares. Based on an average daily volume of 1,830,000 shares, the days-to-cover ratio […]

United-states , Robertw-baird , Markc-schneyer , Stephen-davis , Morgan-stanley , Pharmaceuticals-daily , Empire-life-investments-inc , Pharmaceuticals-trading , Franklin-resources-inc , Pharmaceuticals-company-profile , Group-plc , Acadia-pharmaceuticals-inc

ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) Short Interest Update

ASLAN Pharmaceuticals Limited (NASDAQ:ASLN – Get Free Report) was the recipient of a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 116,800 shares, a decline of 59.8% from the March 15th total of 290,500 shares. Currently, 0.7% of the shares of the company are […]

Piper-sandler , Virtu-financial , Millennium-management , Citigroup-inc , Pharmaceuticals-company-profile , Aslan-pharmaceuticals-limited , Pharmaceuticals-price-performance , Pharmaceuticals-daily , Schonfeld-strategic-advisors , Get-free-report , Strategic-advisors , Aslan-pharmaceuticals

TRACON Pharmaceuticals (NASDAQ:TCON) Shares Scheduled to Reverse Split on Wednesday, April 10th

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Free Report)’s stock is going to reverse split before the market opens on Wednesday, April 10th. The 1-20 reverse split was announced on Wednesday, April 10th. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, April 10th. TRACON Pharmaceuticals Price Performance NASDAQ TCON […]

United-states , Ci-private-wealth , Pharmaceuticals-price-performance , Pharmaceuticals-daily , Susquehanna-international-group , Tracon-pharmaceuticals-inc , Nasdaq , Pharmaceuticals-inc , Pharmaceuticals-company-profile , Charles-schwab-investment-management-inc , Renaissance-technologies

TRACON Pharmaceuticals (NASDAQ:TCON) Shares to Reverse Split on Wednesday, April 10th

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Free Report) shares are set to reverse split on Wednesday, April 10th. The 1-20 reverse split was announced on Wednesday, April 10th. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, April 10th. TRACON Pharmaceuticals Trading Down 24.8 % Shares of TCON traded […]

United-states , Pharmaceuticals-daily , Charles-schwab-investment-management-inc , Susquehanna-international-group , Virtu-financial , Tracon-pharmaceuticals-inc , Pharmaceuticals-company-profile , Pharmaceuticals-inc , Renaissance-technologies , Nasdaq , Pharmaceuticals-trading-down

CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note released on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Performance Shares of CASI Pharmaceuticals stock opened at $3.11 on Friday. CASI Pharmaceuticals has a one year low of $1.85 and […]

United-states , Pharmaceuticals-inc , Virtu-financial , Pharmaceuticals-daily , Pharmaceuticals-stock-performance , Susquehanna-international-group , Citigroup-inc , Renaissance-technologies , Pharmaceuticals-company-profile , Free-report , International-group

TRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note issued to investors on Sunday morning. The firm issued a strong-buy rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their price objective on shares of TRACON Pharmaceuticals from $7.00 to $6.00 and set a buy rating for […]

United-states , Pharmaceuticals-company-profile , Virtu-financial , Pharmaceuticals-inc , Ci-private-wealth , Susquehanna-international-group , Charles-schwab-investment-management-inc , Pharmaceuticals-stock-performance , Pharmaceuticals-daily , Free-report , Get-free-report